251 top medical experts on VLCAD deficiency across 35 countries and 23 U.S. states, including 96 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. VLCAD deficiency: Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency (VLCADD) is an inherited disorder of mitochondrial long-chain fatty acid oxidation with a variable presentation including: cardiomyopathy, hypoketotic hypoglycemia, liver disease, exercise intolerance and rhabdomyolysis.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations

Organizations Providing General Support

  • Synonyms: Acadvl,  Deficiency of Very Long-Chain Acyl-CoA Dehydrogenase,  Acyl-Coa Dehydrogenase Very Long Chain Deficiency,  Pearson Marrow-Pancreas Syndrome,  Pearson syndrome,  Pearson's marrow-pancreas syndrome,  Sideroblastic anemia with marrow cell vacuolization and exocrine pancreatic dysfunction,  Very Long-Chain Acyl Coenzyme A Dehydrogenase Deficiency,  Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency,  Very long-chain acyl-CoA dehydrogenase deficiency,  Vlcad-C,  Vlcad-H


    •   

            

                        


      Computing Expert Listing ...